Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Annals of the New York Academy of Sciences
|
January 16, 2010
Interferon lambda as a potential new therapeutic for hepatitis C
Dennis M Miller, Kevin M Klucher, Jeremy A Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Interleukin-21 signaling: functions in cancer and autoimmunity
Ian D Davis, Kresten Skak, Mark J Smyth, et al.
International Journal of Toxicology
|
June 23, 2012
Preclinical safety, pharmacokinetics, and pharmacodynamics of recombinant human interleukin-21 in cynomolgus macaques (Macaca fascicularis)
Kimberly S Waggie, Matthew S Holdren, Kelly Byrnes-Blake, et al.
Journal of Clinical and Translational Hepatology
|
September 11, 2015
Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic
Henrik Andersen, Jeff Meyer, Jeremy Freeman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
January 28, 2012
Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeys
Kelly A Byrnes-Blake, Susan Pederson, Kevin M Klucher, et al.
Contemporary Clinical Trials Communications
|
August 17, 2021
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients
Miko Yamada, Dennis M Miller, Melinda Lowe, et al.
Journal of Neurosurgery. Pediatrics
|
August 29, 2025
Phase 1 and expanded imaging study of tozuleristide in patients with pediatric primary central nervous system tumors
Amy Lee, Bonnie L Cole, Jeffrey Ojemann, et al.
International Journal of Toxicology
|
April 14, 2017
Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent
Julia Parrish-Novak, Kelly Byrnes-Blake, Narine Lalayeva, et al.
Archives of Pathology & Laboratory Medicine
|
December 15, 2018
Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide
Suzanne M Dintzis, Stacey Hansen, Kristi M Harrington, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 29, 2006
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma
Helen J Ross, Lowell L Hart, Paul M Swanson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Annals of the New York Academy of Sciences
|
January 16, 2010
Interferon lambda as a potential new therapeutic for hepatitis C
Dennis M Miller, Kevin M Klucher, Jeremy A Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 7, 2007
Interleukin-21 signaling: functions in cancer and autoimmunity
Ian D Davis, Kresten Skak, Mark J Smyth, et al.
International Journal of Toxicology
|
June 23, 2012
Preclinical safety, pharmacokinetics, and pharmacodynamics of recombinant human interleukin-21 in cynomolgus macaques (Macaca fascicularis)
Kimberly S Waggie, Matthew S Holdren, Kelly Byrnes-Blake, et al.
Journal of Clinical and Translational Hepatology
|
September 11, 2015
Peginterferon Lambda-1a, a New Therapeutic for Hepatitis C Infection, from Bench to Clinic
Henrik Andersen, Jeff Meyer, Jeremy Freeman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
January 28, 2012
Pharmacokinetics and pharmacodynamics of pegylated interferon lambda-1 in cynomolgus monkeys
Kelly A Byrnes-Blake, Susan Pederson, Kevin M Klucher, et al.
Contemporary Clinical Trials Communications
|
August 17, 2021
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients
Miko Yamada, Dennis M Miller, Melinda Lowe, et al.
Journal of Neurosurgery. Pediatrics
|
August 29, 2025
Phase 1 and expanded imaging study of tozuleristide in patients with pediatric primary central nervous system tumors
Amy Lee, Bonnie L Cole, Jeffrey Ojemann, et al.
International Journal of Toxicology
|
April 14, 2017
Nonclinical Profile of BLZ-100, a Tumor-Targeting Fluorescent Imaging Agent
Julia Parrish-Novak, Kelly Byrnes-Blake, Narine Lalayeva, et al.
Archives of Pathology & Laboratory Medicine
|
December 15, 2018
Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent Tozuleristide
Suzanne M Dintzis, Stacey Hansen, Kristi M Harrington, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 29, 2006
A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma
Helen J Ross, Lowell L Hart, Paul M Swanson, et al.
Page
of 2